02.01
Individual analysis
Individual analysis comes first: relevant biological, clinical, medication and time-related findings are assessed for quality and context, then organized into a structured profile.
Computational Biology · Precision Health
Activate
your core.
Our CCRM (Curetanics Cellular Response Model) is a technology platform that explores how bioactive natural compounds interact with the individual at the cellular and molecular levels. It focuses on cancer therapy support, post-treatment support and prevention.
Individual contextCellular intelligence
Illustrative model of human cellular processes
01 / Innovation
Personalized Bioactive Intelligence
Individual biology is complex. Our research approach is designed to explore that complexity.
Thousands of scientific publications describe biological effects of secondary plant compounds and other bioactive substances. Translating that knowledge into an individual context remains the real challenge.
Curetanics starts with individual analysis and a structured profile, then connects that context with mechanistic evidence. The aim is to explore which compounds may be relevant, for whom, why, at which point in time—and with which constraints.
02 / Technology
CCRM: individual analysis first
CCRM is in operational use for research and responsible expert work. Every analysis starts with the individual biological and clinical context.
In operational use
CCRM — Curetanics Cellular Response Model
From individual analysis to a contextual model
CCRM is an existing model in operational use. Individual analysis is the starting point: relevant findings and their quality, timing and context are assessed before a structured profile is connected with evidence, mechanistic modelling and expert review. Supporting technical, validation and regulatory documentation exists; the detailed records are not reproduced on this website.
Methods, evidence and documentation- Individual analysis
- Available clinical, molecular and laboratory findings, medication and time context are assessed for relevance, quality and completeness before profiling.
- Structured individual profile
- Time-stamped observations, tissue and assay metadata, treatment exposure, units and explicit missing values.
- Mechanistic modelling
- The individual profile provides the context for the evidence graph, exposure constraints and model-based hypotheses.
- Expert review
- Evidence-linked outputs make assumptions, uncertainty and interaction questions inspectable for responsible expert assessment.
02.02
Mechanistic mapping
The knowledge graph connects compounds, targets and pathways with source, assay context and conflicting evidence, interpreted against the individual profile.
02.03
Contextual simulation
Contextual modelling builds on the individual analysis and evidence graph to investigate mechanistic hypotheses. Cellular states require relevant measurements; routine blood tests do not reveal every intracellular state.
02.04
Explainable output
Outputs expose supporting evidence, model assumptions, uncertainty and unresolved questions for expert review.
03 / One continuum
Before.
During.
Beyond.
Cancer does not begin with diagnosis—and health does not end when treatment is completed. Our platform is conceived across the full continuum.
03.1
Before disease
Prevention
Exploring how selected bioactive compounds may support risk-aware, evidence-led strategies in an individual context—even when no diagnosis is present.
03.2
During treatment
Therapy Support
Modeling potential interactions relevant to treatment tolerability, biological resilience and immune function—always as a complement to, never a replacement for, medical care.
03.3
Beyond treatment
Post-Treatment Support
Investigating individualized strategies for recovery, long-term biological support and the reduction of modifiable risk factors during follow-up.
03.1 / Prevention
Knowledge that begins before the patient journey.
Insights generated in a cancer context may also inform prevention-oriented research for people without a diagnosis.
BiologyLifestyleExposureTimingEvidenceSafety
Individual contextPrevention
intelligence
intelligence
Risk-awareEvidence-led
From generalized advice to contextual understanding.
Curetanics investigates how biological vulnerability, exposures, lifestyle, timing and compound mechanisms may relate. The objective is to build differentiated hypotheses—not to promise that cancer can be prevented by any single compound, product or behavior.
Preventive use of any substance should be evaluated for safety, interactions and individual suitability with qualified professionals.
Risk reduction is not a guarantee of cancer prevention.
Learn more03.2 / Therapy Support
Support the system.
Respect the therapy.
The platform explores questions such as how selected compounds could interact with treatment-related biological stress, immune pathways or adverse-effect mechanisms. Any application must be assessed for treatment interactions and aligned with the treating medical team.
TolerabilityImmune contextInteraction safetyAny use of bioactive compounds must always be reviewed and approved by the treating oncologist and medical team.
Learn more03.3 / Post-Treatment Support
Recovery is a biological phase of its own.
After treatment, the individual context continues to evolve. Curetanics studies how evidence around bioactive compounds may contribute to research on recovery, resilience and modifiable factors associated with long-term health.
RecoveryLong-term contextFollow-upAny use of bioactive compounds must always be reviewed and approved by the treating oncologist and medical team.
Learn more04 / Science & Evidence
Evidence before assertion
Mechanistic depth.
Transparent uncertainty.
Scientific knowledge is dynamic, incomplete and context-dependent. Our approach is designed to distinguish signals from conclusions and hypotheses from validated findings.
05 / About Curetanics
Biology, viewed through a technological lens.
Curetanics is a technology-driven initiative working at the intersection of computational biology, bioactive compound science and precision health. Cancer is our primary field of application; the platform itself is built to understand complex biological interactions.
Our business units
CCRM
We build models, evidence structures and decision-support concepts intended for research and responsible expert use.
We do not develop or provide medical treatment.
Learn moreCuretanics Shop
A specialist online shop in development for healthcare professionals and people receiving medically supervised care, focused on cancer prevention, supportive care during cancer therapy and post-treatment care.
06 / Network
Affiliates · Enablers · Supporters
Progress is
a collective effort.
A special thank you to the whole network of affiliates, enablers and supporters along our mission.
06.01
Medical
- Fudan University Shanghai Cancer CenterChina
- Institut Gustave RoussyFrance
- The University of Texas MD Anderson Cancer CenterUSA
- Vanderbilt-Ingram Cancer CenterUSA
- Cancer Research UKUK
06.02
Technical
- NVIDIA Inception ProgramUSA
- OpenAI for StartupsUSA
- Lenovo ProChina
06.03
Financial
- National Venture Capital Guidance FundChina
- French Tech 2030France
- NIH SEEDUSA
Organizations are acknowledged in the context of the stated network. Inclusion does not by itself imply endorsement of Curetanics, its technology or specific applications.
Start a conversation
Let’s explore what becomes possible when biology meets context.
Research · Technology · Strategic partnerships
contact@curetanics.comLegal
Imprint & Privacy
Legal Notice
Information pursuant to Section 5 of the German Digital Services Act (DDG)
CURETANICS
Hildegard-von-Bingen-Str. 11
64560 Riedstadt
Germany
Represented by
Marcus Peruscha
Contact
Email: contact@curetanics.com
Person responsible for content
Marcus Peruscha
Hildegard-von-Bingen-Str. 11
64560 Riedstadt
Germany
Privacy Notice
Controller
CURETANICS
Hildegard-von-Bingen-Str. 11
64560 Riedstadt
Germany
Email: contact@curetanics.com
Hosting via ChatGPT Sites
This website is hosted via ChatGPT Sites by OpenAI. When you visit the website, technically necessary connection and log data may be processed, including your IP address, the time of access, the requested resource, and browser and device information. This processing serves to provide, secure, maintain and support the website. OpenAI processes hosted data under the agreements and privacy terms applicable to the account used. For further information, please refer to the ChatGPT Sites Terms and the ChatGPT Sites Data Processing Addendum. The specific storage and hosting regions depend on the applicable OpenAI agreement and its settings.
Contacting us
If you contact us by email, we process the data you provide in order to respond to your enquiry. Depending on the subject of your enquiry, processing is carried out either to take steps prior to entering into a contract or on the basis of our legitimate interest in appropriate communication. We delete this data once your enquiry has been fully resolved, unless statutory retention obligations require us to retain it.
Cookies, analytics and marketing
This website does not use analytics or marketing services and does not set non-essential cookies. Technically necessary functions of the hosting service remain unaffected. If additional services are added to the website in the future, this Privacy Notice will be updated accordingly before they are used.
Your rights
Where the legal requirements are met, data subjects may request access, rectification, erasure, restriction of processing and data portability, object to processing, and withdraw consent previously given. Data subjects also have the right to lodge a complaint with a data protection supervisory authority.
Last updated
October 2026